An analysis of tuberculosis mortality in the US indicates a forecast of a constant rate of 200 male deaths per hundred men from 2024 to 2028. Compared to 2023, there is no observed change in the numbers, suggesting stability in the rate of tuberculosis-related mortality among males over this period. The lack of year-on-year variation highlights a steady state with no increase or decrease in mortality, marking a 0% change across all forecasted years. The Compound Annual Growth Rate (CAGR) from 2024 to 2028 remains stagnant at 0%.
Future trends to watch for include advancements in medical treatment and public health policies that could influence tuberculosis mortality rates. Monitoring the impact of emerging healthcare technologies and prevention programs is essential, as they could potentially alter the current forecast and stabilize or further reduce mortality rates in the following years. Additionally, changes in healthcare access and funding may also play a significant role in shaping future tuberculosis outcomes.
